Experience with antiviral agents for treatment of hepatitis C virus infection in hemodialysis patients on the kidney wait list-Reference-Cited by-同舟云学术

Experience with antiviral agents for treatment of hepatitis C virus infection in hemodialysis patients on the kidney wait list

Published:2019-02-14 Issue:3 Volume:23 Page:E78-E82
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Torun Dilek¹,Soydas Baris²,Tekkarismaz Nihan¹,Ozelsancak Ruya¹,Micozkadioglu Hasan¹,Haberal Mehmet³

Affiliation:

1. Department of Nephrology, Adana Dr Turgut Noyan Research and Medical Center; Baskent University Faculty of Medicine; Adana Turkey

2. Department of Gastroenterology, Adana Dr Turgut Noyan Research and Medical Center; Baskent University Faculty of Medicine; Adana Turkey

3. Department of Transplantation and General Surgery; Baskent University Faculty of Medicine; Adana Turkey

Funder

Baskent University Research Fund

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12719/fullpdf

Reference28 articles.

1. National surveillance of dialysis associated diseases in the United States, 2002;Finelli;Semin Dial,2005

2. Current Status of Renal Replacement Therapies in Turkey: Turkish Society of Nephrology Registry 2015 Summary Report;Seyahi;Turk Neph Dial Transpl,2017

3. The impact of hepatitis C virus infection on survival in dialysis patients: Meta-analysis of observational studies;Fabrizi;J Viral Hepat,2007

4. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection;Satapathy;Hepatol Int,2012

5. Kidney transplantation in the patient with hepatitis C virus infection;Morales;Contrib Nephrol,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation;World Journal of Clinical Cases;2023-09-16

2. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

3. Assessing Responsiveness of Elevated Serum Ferritin for Treatment in Chronic Hepatitis C Infected Patients;Pakistan Journal of Medical and Health Sciences;2021-06-30

4. Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience;Revista da Associação Médica Brasileira;2019-12

5. The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience;Viral Hepatitis Journal;2019-12-01